Eleven Biotherapeutics (EBIO) Swings to Q3 Profit

November 14, 2016 7:11 AM EST
Get Alerts EBIO Hot Sheet
Trade EBIO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Eleven Biotherapeutics (NASDAQ: EBIO) reported Q3 EPS of $0.95, versus $0.50 reported last year. Revenue for the quarter came in at $28.7 million, versus $100 thousand reported last year.

For earnings history and earnings-related data on Eleven Biotherapeutics (EBIO) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment